| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2018-08-09 |
详情>>
股本变动：
变动后总股本3724.01万股
|
| 2018-07-31 |
复牌提示：
2018-07-31 08:30:40 停牌，复牌日期 2018-08-01 00:00:01
|
| 2018-07-02 |
详情>>
内部人交易：
Cox Troy等共交易7笔
|
| 2018-05-02 |
财报披露：
美东时间 2018-05-02 盘后发布财报
|
| 2018-05-02 |
详情>>
业绩披露：
2018年一季报每股收益-1.02美元,归母净利润-3741.5万美元,同比去年增长19.46%
|
| 2018-04-27 |
股东大会：
将于2018-06-21召开股东大会
会议内容 ▼▲
- 1.to elect nine directors to serve as directors until the 2019 annual meeting of stockholders and until their successors are duly elected and qualified, subject to their earlier resignation or removal;
2.to ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2018;
3.to transact such other business as may properly come before the meeting or at any and all adjournments or postponements thereof.
|
| 2018-03-07 |
财报披露：
美东时间 2018-03-07 盘后发布财报
|
| 2018-03-07 |
详情>>
业绩披露：
2017年年报每股收益-4.5美元,归母净利润-1.61亿美元,同比去年增长-42.65%
|
| 2018-03-07 |
详情>>
业绩披露：
2015年年报每股收益-2.73美元,归母净利润-8963.1万美元,同比去年增长-71.18%
|
| 2017-11-01 |
财报披露：
美东时间 2017-11-01 盘后发布财报
|
| 2017-11-01 |
详情>>
业绩披露：
2017年三季报(累计)每股收益-3.45美元,归母净利润-1.23亿美元,同比去年增长-59%
|
| 2017-08-01 |
详情>>
业绩披露：
2017年中报每股收益-2.55美元,归母净利润-9071.1万美元,同比去年增长-95.92%
|
| 2017-05-09 |
详情>>
业绩披露：
2017年一季报每股收益-1.31美元,归母净利润-4645.3万美元,同比去年增长-168.41%
|
| 2017-04-28 |
股东大会：
将于2017-06-20召开股东大会
会议内容 ▼▲
- 1.to elect nine directors to serve as directors until the 2018 annual meeting of stockholders and until their successors are duly elected and qualified, subject to their earlier resignation or removal;
2.to ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2017;
3.to transact such other business as may properly come before the meeting or at any and all adjournments or postponements thereof.
|
| 2017-03-03 |
详情>>
业绩披露：
2016年年报每股收益-3.25美元,归母净利润-1.13亿美元,同比去年增长-26.29%
|
| 2017-03-03 |
详情>>
业绩披露：
2014年年报每股收益-1.87美元,归母净利润-5236.1万美元,同比去年增长-21.54%
|
| 2016-11-02 |
详情>>
业绩披露：
2016年三季报(累计)每股收益-2.24美元,归母净利润-7758.3万美元,同比去年增长-9.87%
|
| 2016-08-03 |
详情>>
业绩披露：
2016年中报每股收益-1.34美元,归母净利润-4630.1万美元,同比去年增长7.43%
|
| 2016-05-03 |
详情>>
业绩披露：
2016年一季报每股收益-0.5美元,归母净利润-1730.7万美元,同比去年增长-2.02%
|
| 2016-04-27 |
股东大会：
将于2016-06-16召开股东大会
会议内容 ▼▲
- 1. to elect eight directors to serve as directors until the 2017 annual meeting of stockholders and until their successors are duly elected and qualified, subject to their earlier resignation or removal;
2. to ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2016;
3. to transact such other business as may properly come before the meeting or at any and all adjournments or postponements thereof.
|
| 2015-04-30 |
股东大会：
将于2015-06-18召开股东大会
会议内容 ▼▲
- 1. to elect eight directors to serve as directors until the 2016 annual meeting of stockholders and until their successors are duly elected and qualified, subject to their earlier resignation or removal;
2. to ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2015;
3. to transact such other business as may properly come before the meeting or at any and all adjournments or postponements thereof.
|
| 2015-02-19 |
股东大会：
将于2015-04-02召开股东大会
会议内容 ▼▲
- 1.to approve the Transaction Agreement, dated as of January 11, 2015, as amended from time to time (the “Transaction Agreement”), by and between Foundation and Roche Holdings, Inc. (“Roche”), and the transactions contemplated thereby, including the issuance of 5.0 million shares of our common stock to Roche at a price of $50.00 per share;
2.to approve the anti-dilution protections granted to Roche in the Investor Rights Agreement, dated as of January 11, 2015, as amended from time to time (the “Investor Rights Agreement”), by and between Foundation and Roche, that will become effective upon closing of the transactions contemplated by the Transaction Agreement;
3.to approve the proposed amendment to our Certificate of Incorporation (the “Certificate of Incorporation”) to declassify our Board of Directors, provide for the annual election of directors and permit the removal of directors with or without cause;
4.to approve the proposed amendment to our Certificate of Incorporation to renounce Foundation’s expectancy regarding certain corporate opportunities;
5.to approve one or more adjournments of the Special Meeting from time to time if necessary or appropriate (as determined by Foundation) to solicit additional proxies if there are not sufficient votes to approve any of Proposals 1 through 4;
6.to transact any other business that may properly come before the Special Meeting or any adjournment or postponement thereof by or at the direction of the Board of Directors.
|
| 2014-04-30 |
股东大会：
将于2014-06-18召开股东大会
会议内容 ▼▲
- 1. to elect two directors, Brook Byers and Michael Pellini, M.D., to serve as Class I directors until the 2017 annual meeting of stockholders and until their successors are duly elected and qualified, subject to their earlier resignation or removal;
2. to ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2014;
3. to ratify the 2013 Stock Option and Incentive Plan;
4. to transact such other business as may properly come before the meeting or at any and all adjournments or postponements thereof.
|